Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07076082 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vascular Trial Associated Registry Pilot

Study acronym: VSTAR-P
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 1 of 2 sitesv5
  2. Study sites revised (2)v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 1 to 2
    • Primary completion date: Aug 30, 2027 to Oct 30, 2027
    • Study completion date: Aug 30, 2028 to Oct 30, 2028
    • Start date changed from estimate of Aug 30, 2025 to Oct 15, 2025
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this investigator-initiated, multicenter, open label, randomized trial is to evaluate 1 month vs. 6 months of dual antiplatelet therapy (DAPT) in patients undergoing lower extremity endovascular revascularization. We hypothesize that extending dual antiplatelet therapy (DAPT) to six months, compared to one month, will improve patency rates of target vessels following peripheral vascular intervention (PVI) without significantly increasing complications, particularly bleeding events.
Trial Details
NCT Number NCT07076082
Lead Sponsor Corewell Health West
Collaborators: Henry Ford Hospital
Conditions
(from sponsor)		 Peripheral Arterial Disease
Related terms Peripheral Arterial Disease, Peripheral Vascular Diseases
Enrollment 350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov